Article CommentaryCommentary
Managing Excipient Supplier Name and Address Changes in the Pharmaceutical Quality System
Richard Rolke, Emma Ramnarine, Anders Vinther and Anil Sawant
PDA Journal of Pharmaceutical Science and Technology March 2020, 74 (2) 286-288; DOI: https://doi.org/10.5731/pdajpst.2019.011239
Richard Rolke
1Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Lansdale, PA, USA;
Emma Ramnarine
2Genentech/Roche, South San Francisco, CA, USA;
Anders Vinther
3Intarcia Therapeutics, Hayward, CA, USA; and
Anil Sawant
4Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ, USA

References
- 1.↵International Conference for Harmonization, Quality Guideline Q12: Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management. ICH: Geneva, 2019. https://www.ich.org/page/quality-guidelines (accessed Aug 15, 2019).
- 2.↵International Conference for Harmonization, Quality Guideline Q10: Pharmaceutical Quality System. ICH: Geneva, 2010. http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html (accessed Aug 15, 2019).
- 3.↵International Conference for Harmonization, Quality Guideline Q9: Quality Risk Management. ICH: Geneva, 2006. http://www.ich.org/products/guidelines (accessed Aug 15, 2019).
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 74, Issue 2
March/April 2020
Managing Excipient Supplier Name and Address Changes in the Pharmaceutical Quality System
Richard Rolke, Emma Ramnarine, Anders Vinther, Anil Sawant
PDA Journal of Pharmaceutical Science and Technology Mar 2020, 74 (2) 286-288; DOI: 10.5731/pdajpst.2019.011239
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.